Pharmaceutical Raw Material, API and Packaging Warehousing

Define the material and regulatory role

API, excipient, primary, printed or secondary packaging, origin, intended use, client and operator roles are documented before acceptance. A general GMP or GDP reference does not replace product qualification or required authorisation.

Apply the specific GDP framework for APIs

EU GDP guidance specifically covers distributors of active substances for human medicines. Supplier and customer, original labelling, batch, agreed certificates, storage and transport conditions and traceability are assessed separately from finished medicines.

Qualify excipients by risk

Material properties, supply chain, specification, temperature, humidity and contamination risks determine the storage concept. Release remains with the accountable quality function.

Separate primary, printed and secondary packaging

Product-contact and printed materials require stricter identity, status, protection and access controls than suitable secondary packaging. Item version, lot, supplier, release, damage and use status are maintained.

Control quarantine, release, rejection and sampling interfaces

Statuses are clearly segregated. Sampling, testing and release only occur within a confirmed role, premises and hygiene scope or are handed to the responsible quality-control function.

Translate specifications into storage controls

Temperature, humidity, light, closure integrity, cleaning, pests, odour, dust, cross-contamination, hazardous-material and security requirements determine segregation, monitoring and escalation.

Assess a Cheb materials project

We need material type, specification and safety data, supplier and origin, packaging, temperature and humidity, volumes, status model, sampling and release process, interfaces, recipients and start date before confirming capacity.

Official sources for materials and packaging

• EU GDP guidelines for active substances (2015/C 95/01) →
• EudraLex Volume 4 – EU GMP guide →
• EU GMP Chapter 3 – premises and equipment →
• EU GMP Chapter 4 – documentation →
• EU GMP Chapter 5 – production and material control →

Applicability depends on material, activity, role and authorisation scope. These sources establish requirements; they do not prove certification or acceptance capability for Inter-Pharma.